Outcomes of antiviral retreatment for immunocompromised hosts with prolonged Severe Acute Respiratory Syndrome Coronavirus 2 polymerase chain reaction positivity: A multicenter Australian retrospective case series
Citation
K A Bond, C Dendle, S Guy, M A Slavin, O Smibert, N Ibrahim, P M Kinsella, C O Morrissey, M A Moso, J J Sasadeusz
Open Forum Infectious Diseases, 2024 Aug 7;11(8):ofae449. DOI: https://doi.org/10.1093/ofid/ofae449
Abstract
Outcomes are presented for a multisite retrospective case series, describing a contemporary cohort of 22 immunocompromised patients with persistent coronavirus disease 2019 (COVID-19) polymerase chain reaction positivity who were retreated with antiviral therapy. For those with data available 14 and 30 days after commencement of antiviral therapy, 41% (9 of 22) and 68% (15 of 22), respectively, cleared COVID-19.